Patients with peripheral arterial disease (PAD) are at very high risk of cardiovascular events,
but risk factor management is usually suboptimal. This Joint Task Force from the European …

Peripheral arterial disease (PAD) is a highly prevalent atherosclerotic condition. In patients
with PAD, the presence of intermittent claudication leads to a deterioration in quality of life. In …

Objective Statin therapy is indicated in patients with peripheral arterial disease (PAD).
National Institute for Health and Care Excellence guidelines suggest the use of “high …

Effective methods to educate physicians and patients on best medical management are
needed. Further research is needed to examine the benefit of LDL-c lowering and other lipid …

Background: The global burden of peripheral arterial disease (PAD) is substantial. Reducing
the major modifiable risk factors for noncommunicable disease, including dyslipidaemia …

Background Patients diagnosed with peripheral arterial disease (PAD) are at an increased
risk of coronary heart disease, stroke, heart attack, and PAD progression. If diagnosed early …

Objective There are lack of studies considering the suboptimal management of dyslipidemia
especially in cardiology outpatient clinics. This study was conducted to assess the patient …

Aim Peripheral arterial disease (PAD) and coronary artery disease (CAD) are both caused
by atherosclerosis. Serum lipids and lipoproteins are predictive of the development of …

Background and aims Lipid goals have become more stringent in high risk patients.
However, no studies have analyzed lipid control defined as the composite achievement of …

Peripheral artery disease (PAD) is estimated to affect approximately 8.5 million individuals in
the US above the age of 40, and is associated with significant morbidity, mortality, and …